- CFO Spotlights
- Profiles
- Nicholas M. Maestas
Profile
Nicholas M. Maestas
Chief Financial Officer (principal financial officer and principal accounting officer), Rani Therapeutics Holdings, Inc.
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Nicholas M. Maestas has been Chief Financial Officer (principal financial officer and principal accounting officer) of Rani Therapeutics Holdings, Inc. since June 29, 2026, according to the company's filing of June 30, 2026.1
The filing gives Nicholas M. Maestas's previous role as Chief Financial Officer and Head of Corporate Strategy at Tempest Therapeutics, Inc.1 Nicholas M. Maestas joined from outside Rani Therapeutics Holdings, Inc., by the record's reading of the filing.1 The filing shows an earlier chief financial officer seat, so this is not Nicholas M. Maestas's first.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) Pharmaceutical Preparations | Chief Financial Officer (principal financial officer and principal accounting officer) | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- June 29, 2026effective
Rani Therapeutics Holdings, Inc. appointed Nicholas M. Maestas as Chief Financial Officer (principal financial officer and principal accounting officer), effective June 29, 2026. Profile of Svai Sanford.
Maestas as the Company’s Chief Financial Officer (principal financial officer and principal accounting officer) effective as of June 29, 2026.
[1] Filing by Rani Therapeutics Holdings, Inc., filed with the SEC on June 30, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Current report filed with the SEC, Rani Therapeutics Holdings, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed June 30, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Nicholas M. Maestas wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.